Highlights from Novo Nordisk A/S’s Capital Markets Day 2011

BAGSVAERD, DENMARK--(Marketwire - May 05, 2011) -



At its Capital Markets Day today, Novo Nordisk outlines the aspirations for how to sustain competitiveness in the global pharmaceutical industry.




Company Announcement no 27 2011: http://hugin.info/2013/R/1512418/448279.pdf




This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1512418]


Media:
Mike Rulis
Tel: (+45) 4442 3573
Email Contact

In North America
Ken Inchausti
Tel: (+1) 609 786 8316
Email Contact

Investors:
Klaus Bulow Davidsen
Tel: (+45) 4442 3176
Email Contact

Jannick Lindegaard
Tel: (+45) 4442 4765
Email Contact

Frank Daniel Mersebach
Tel: (+45) 4442 0604
Email Contact

In North America
Hans Rommer
Tel: (+1) 609 216 4834
Email Contact

MORE ON THIS TOPIC